Phase 2 Stomach Cancer Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who have been diagnosed with gastric cancer with peritoneal metastases (cancer that has spread to the lining of the abdomen), confirmed by a tissue sample, and/or have cancer cells found in fluid around the abdomen, and who have already completed at least 2 to 4 months of chemotherapy.
• People aged 18 years or older.
• People who are reasonably well and able to carry out some daily activities, as measured by a standard medical scale (confirm with trial site for exact threshold).
• People whose blood counts and organ function (including white blood cells, platelets, liver, and kidneys) meet minimum levels set by the trial (confirm with trial site for exact values).
• People living with HIV who are on effective treatment and whose virus levels in the blood have been undetectable within the past 6 months.
• People with a history of hepatitis B who are on appropriate treatment and whose virus levels are undetectable.
• People with a history of hepatitis C who have been successfully treated and cured, or who are currently on hepatitis C treatment with undetectable virus levels.
• People who have had another cancer in the past, or who have one at the same time, as long as that cancer or its treatment is unlikely to affect the safety or results of this trial (confirm with trial site).
• People with a history of heart disease or prior treatment with heart-affecting medicines, provided a standard heart function assessment rates them at a certain level or better (confirm with trial site for exact classification).
• People with an expected survival of more than 3 months.
• People who are able to use reliable contraception (such as hormonal methods, barrier methods, or abstinence) during the trial and for a set period afterward, given that the medicines used in this trial can harm an unborn baby.
• People who are willing and able to understand and sign a written consent form.

Who may not be able to join:

• People who currently have another untreated cancer (other than a common type of skin cancer called basal cell carcinoma) diagnosed within the last five years.
• People whose cancer has spread to organs beyond the peritoneum and nearby lymph nodes — for example, to the liver, lungs, bones, or brain.
• People who have not yet recovered from side effects of previous cancer treatment, where those side effects are still rated above a mild level (with the exception of hair loss).
• People who are currently taking part in another clinical trial involving an experimental treatment.
• People who have had a serious allergic reaction to medicines chemically similar to cisplatin or Mitomycin C, which are the drugs used in this trial.
• People with other serious illnesses that are not well controlled.
• People with psychiatric conditions or personal circumstances that would make it difficult to follow the trial requirements.
• People who are pregnant, as the trial medicines carry a known risk of harm to unborn babies.
• People who are breastfeeding, as it is unknown whether the trial medicines could affect a nursing infant.

Important: Always verify eligibility with the trial site directly before applying.